Literature DB >> 17076989

The key role of adult stem cells: therapeutic perspectives.

Augusto Pessina1, Laura Gribaldo.   

Abstract

BACKGROUND: The origin, function and physiology of totipotent embryonic cells are configured to construct organs and create cross-talk between cells for the biological and neurophysiologic development of organisms. Adult stem cells are involved in regenerating tissues for renewal and damage repair.
FINDINGS: Adult stem cells have been isolated from adult tissue, umbilical cord blood and other non-embryonic sources, and can transform into many tissues and cell types in response to pathophysiological stimuli. Clinical applications of adult stem cells and progenitor cells have potential in the regeneration of blood cells, skin, bone, cartilage and heart muscle, and may have potential in degenerative diseases. Multi-pluripotent adult stem cells can change their phenotype in response to trans-differentiation or fusion and their therapeutic potential could include therapies regulated by pharmacological modulation, for example mobilising endogenous stem cells and directing them within a tissue to stimulate regeneration. Adult stem cells could also provide a vehicle for gene therapy, and genetically-engineered human adult stem cells have shown success in treatment of genetic disease.
CONCLUSION: Deriving embryonic stem cells from early human embryos raises ethical, legal, religious and political questions. The potential uses of stem cells for generating human tissues are the subject of ongoing public debate. Stem cells must be used in standardised and controlled conditions in order to guarantee the best safety conditions for the patients. One critical point will be to verify the risk of tumourigenicity; this issue may be more relevant to embryonic than adult stem cells.

Entities:  

Mesh:

Year:  2006        PMID: 17076989     DOI: 10.1185/030079906X148517

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  19 in total

Review 1.  Stem cells and genetic disease.

Authors:  A Mackay-Sim; P Silburn
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

Review 2.  Cancer stem cells as a potential therapeutic target in breast cancer.

Authors:  Mingzhi Zhang; Zhaoming Li; Xudong Zhang; Yu Chang
Journal:  Stem Cell Investig       Date:  2014-07-16

3.  Sonic Hedgehog Effectively Improves Oct4-Mediated Reprogramming of Astrocytes into Neural Stem Cells.

Authors:  Hao Yang; Cuicui Liu; Hong Fan; Bo Chen; Dageng Huang; Lingling Zhang; Qian Zhang; Jing An; Jingjing Zhao; Yi Wang; Dingjun Hao
Journal:  Mol Ther       Date:  2019-05-16       Impact factor: 11.454

4.  Efficient Conversion of Spermatogonial Stem Cells to Phenotypic and Functional Dopaminergic Neurons via the PI3K/Akt and P21/Smurf2/Nolz1 Pathway.

Authors:  Hao Yang; Yang Liu; Yanan Hai; Ying Guo; Shi Yang; Zheng Li; Wei-Qiang Gao; Zuping He
Journal:  Mol Neurobiol       Date:  2014-11-06       Impact factor: 5.590

5.  Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage.

Authors:  Annamari Heiskanen; Tia Hirvonen; Hanna Salo; Ulla Impola; Anne Olonen; Anita Laitinen; Sari Tiitinen; Suvi Natunen; Olli Aitio; Halina Miller-Podraza; Manfred Wuhrer; André M Deelder; Jari Natunen; Jarmo Laine; Petri Lehenkari; Juhani Saarinen; Tero Satomaa; Leena Valmu
Journal:  Glycoconj J       Date:  2008-11-27       Impact factor: 2.916

Review 6.  Stem cells in clinical practice: applications and warnings.

Authors:  Daniele Lodi; Tommaso Iannitti; Beniamino Palmieri
Journal:  J Exp Clin Cancer Res       Date:  2011-01-17

7.  Risk factors in the development of stem cell therapy.

Authors:  Carla A Herberts; Marcel S G Kwa; Harm P H Hermsen
Journal:  J Transl Med       Date:  2011-03-22       Impact factor: 5.531

Review 8.  Potential of Mesenchymal Stem Cell based application in Cancer.

Authors:  Sushilkumar Ramdasi; Shabari Sarang; Chandra Viswanathan
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-04-01

9.  Production of a recombinant antibody specific for i blood group antigen, a mesenchymal stem cell marker.

Authors:  Tia Hirvonen; Heli Suila; Sari Tiitinen; Suvi Natunen; Marja-Leena Laukkanen; Annika Kotovuori; Mirka Reinman; Tero Satomaa; Kaija Alfthan; Saara Laitinen; Kristiina Takkinen; Jarkko Räbinä; Leena Valmu
Journal:  Biores Open Access       Date:  2013-10

10.  Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease).

Authors:  Daniel G Cacione; Frederico do Carmo Novaes; Daniel H Moreno
Journal:  Cochrane Database Syst Rev       Date:  2018-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.